Skip to search formSkip to main contentSkip to account menu

Budesonide 0.25 MG/ML Inhalant Solution [Pulmicort]

Known as: BUDESONIDE 0.5 mg in 2 mL RESPIRATORY (INHALATION) SUSPENSION [PULMICORT RESPULES], Pulmicort Respules 0.25 MG/ML Inhalant Solution, Pulmicort Respules 0.5 MG per 2 mL Inhalant Suspension 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Background Inhaled corticosteroids provide unique systems for local treatment of asthma or chronic obstructive pulmonary disease… 
2010
2010
  • Xu Li
  • 2010
  • Corpus ID: 75362182
Aim To observe the treatment effects of magnesium sulfate on bronchiolitis.To study therapeutic effect of atomization inhalation… 
2009
2009
Objective:To evaluate the therapeutic effect of bricanyl and pulmicort respules by nebulized inhalation in treatment of infants… 
2007
2007
Budesonide is a white to off-white, tasteless, odorless powder that is practically insoluble in water and in heptane, sparingly… 
2007
2007
Objective To investigate the clinical effect of air compressor pump atomizing inhalation with pulmicort respules on idiopathic… 
2006
2006
Objective The curative effect of combined application of Puimicort Respules and Bircanyl Nebuliaing solution to treat children's… 
2006
2006
Objective To investigate the clinical effects of ventolinum and pulmicore respules in atomizing inhalation on bronchiolitis… 
2006
2006
Objective To investigate the clinical effects of BRICANYL solution for nebulisation and pulmicore respules in atomizing… 
2006
2006
OBJECTIVE To observe the effect of three-stage sequential method (TSSM) on interleukin-5 (IL-5) mRNA expression in the lung… 
2003
2003
Objective:To investigate the clinical effects of pulmicort respules(budsonide nebulising suspension)inhalation on bronchiolitis…